Cargando…
Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study
BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteristics and clinical course of long-term survivors...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845127/ https://www.ncbi.nlm.nih.gov/pubmed/33509224 http://dx.doi.org/10.1186/s12957-021-02145-1 |
_version_ | 1783644493992427520 |
---|---|
author | Kamada, Yasuyuki Hida, Koya Ishibashi, Haruaki Sako, Shouzou Mizumoto, Akiyoshi Ichinose, Masumi Padmanabhan, Naveen Yoshida, Shinya Yonemura, Yutaka |
author_facet | Kamada, Yasuyuki Hida, Koya Ishibashi, Haruaki Sako, Shouzou Mizumoto, Akiyoshi Ichinose, Masumi Padmanabhan, Naveen Yoshida, Shinya Yonemura, Yutaka |
author_sort | Kamada, Yasuyuki |
collection | PubMed |
description | BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteristics and clinical course of long-term survivors with CRC-PM beyond 5 years. The objective of this study was to identify the clinical and oncological features affecting long-term survival of CRC-PM after comprehensive treatment. METHODS: Between January 1990 and April 2015, CRC-PM patients who underwent CRS with or without HIPEC in two Japanese tertiary hospitals were analyzed. Clinicopathological parameters and therapeutic details for long-term survivors (patients surviving ≥ 5 years after CRS) were described and compared with those for non-survivors (patients surviving < 5 years). RESULTS: The study identified 236 patients with CRC-PM who underwent CRS, with a median follow-up period of 2.5 years. Thirty-three patients (14.0%) were considered as long-term survivors. Compared with non-survivors, long-term survivors had a lower median peritoneal cancer index (PCI) [4 (1–27) vs 9 (0–39), p < 0.001]. Complete cytoreduction (CCR-0) was achieved in all long-term survivors, with a significantly higher rate [33/33 (100%) vs 141/203 (69.8%), p < 0.001]. Metachronous onsets of PM were more frequently observed in the long-term survivor group [26/33 (78.8%) vs 103/203 (50.3%), p = 0.018]. Regarding histopathology, long-term survivors more frequently had mucinous adenocarcinoma than non-survivors [8/33 (24.2%) vs 27/203 (13.3%)] and less likely exhibited poorly differentiated or signet ring cell carcinoma [2/33 (6.1%) vs 48/203 (23.7%)] (p < 0.001). CONCLUSIONS: One in seven patients with CRC-PM achieved the long-term milestone after CRS. A long-term survival was associated with the presence of low PCI, CCR-0, metachronous onset, and mucinous histology. |
format | Online Article Text |
id | pubmed-7845127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78451272021-02-01 Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study Kamada, Yasuyuki Hida, Koya Ishibashi, Haruaki Sako, Shouzou Mizumoto, Akiyoshi Ichinose, Masumi Padmanabhan, Naveen Yoshida, Shinya Yonemura, Yutaka World J Surg Oncol Research BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteristics and clinical course of long-term survivors with CRC-PM beyond 5 years. The objective of this study was to identify the clinical and oncological features affecting long-term survival of CRC-PM after comprehensive treatment. METHODS: Between January 1990 and April 2015, CRC-PM patients who underwent CRS with or without HIPEC in two Japanese tertiary hospitals were analyzed. Clinicopathological parameters and therapeutic details for long-term survivors (patients surviving ≥ 5 years after CRS) were described and compared with those for non-survivors (patients surviving < 5 years). RESULTS: The study identified 236 patients with CRC-PM who underwent CRS, with a median follow-up period of 2.5 years. Thirty-three patients (14.0%) were considered as long-term survivors. Compared with non-survivors, long-term survivors had a lower median peritoneal cancer index (PCI) [4 (1–27) vs 9 (0–39), p < 0.001]. Complete cytoreduction (CCR-0) was achieved in all long-term survivors, with a significantly higher rate [33/33 (100%) vs 141/203 (69.8%), p < 0.001]. Metachronous onsets of PM were more frequently observed in the long-term survivor group [26/33 (78.8%) vs 103/203 (50.3%), p = 0.018]. Regarding histopathology, long-term survivors more frequently had mucinous adenocarcinoma than non-survivors [8/33 (24.2%) vs 27/203 (13.3%)] and less likely exhibited poorly differentiated or signet ring cell carcinoma [2/33 (6.1%) vs 48/203 (23.7%)] (p < 0.001). CONCLUSIONS: One in seven patients with CRC-PM achieved the long-term milestone after CRS. A long-term survival was associated with the presence of low PCI, CCR-0, metachronous onset, and mucinous histology. BioMed Central 2021-01-28 /pmc/articles/PMC7845127/ /pubmed/33509224 http://dx.doi.org/10.1186/s12957-021-02145-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kamada, Yasuyuki Hida, Koya Ishibashi, Haruaki Sako, Shouzou Mizumoto, Akiyoshi Ichinose, Masumi Padmanabhan, Naveen Yoshida, Shinya Yonemura, Yutaka Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title | Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title_full | Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title_fullStr | Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title_full_unstemmed | Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title_short | Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
title_sort | thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845127/ https://www.ncbi.nlm.nih.gov/pubmed/33509224 http://dx.doi.org/10.1186/s12957-021-02145-1 |
work_keys_str_mv | AT kamadayasuyuki thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT hidakoya thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT ishibashiharuaki thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT sakoshouzou thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT mizumotoakiyoshi thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT ichinosemasumi thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT padmanabhannaveen thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT yoshidashinya thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy AT yonemurayutaka thirtythreelongtermsurvivorsaftercytoreductivesurgeryinpatientswithperitonealmetastasesfromcolorectalcanceraretrospectivedescriptivestudy |